Avanafil as a Novel Therapeutic Agent Against LPS-Induced Acute Lung Injury via Increasing CGMP to Downregulate the TLR4-NF-?B-NLRP3 Inflammasome Signaling Pathway için istatistikler
Toplam ziyaret
| views | |
|---|---|
| Avanafil as a Novel Therapeutic Agent Against LPS-Induced Acute Lung Injury via Increasing CGMP to Downregulate the TLR4-NF-?B-NLRP3 Inflammasome Signaling Pathway | 7 |
Aylık toplam ziyaret
| views | |
|---|---|
| Eylül 2025 | 0 |
| Ekim 2025 | 0 |
| Kasım 2025 | 0 |
| Aralık 2025 | 2 |
| Ocak 2026 | 1 |
| Şubat 2026 | 3 |
| Mart 2026 | 1 |
